Glenmark Of India, Taro of U.S. Sign License-Supply Deal
This article was originally published in PharmAsia News
Executive Summary
India's Glenmark Pharmaceuticals, acting through its U.S. unit, Glenmark Generics, has signed a license and supply deal with a unit of U.S.-based Taro Pharmaceuticals